Two methods of extracorporeal shock-wave therapy in a rat model of secondary lymphedema: a pilot study

Objectives To compare the effectiveness of two methods of extracorporeal shock-wave therapy (ESWT) in a rat model of forelimb lymphedema, induced by axillary lymph node dissection. Methods Sprague–Dawley rats were randomly allocated to a group that received 500 ESWT shocks only in the lymphedematous forelimb (Forelimb/ESWT) and a group that received 300 ESWT shocks in the axilla and 200 shocks in the lymphedematous forelimb (Axilla+Forelimb/ESWT). The circumferences of each limb were then measured. Immunohistochemistry for a pan-endothelial marker (cluster of differentiation [CD]31) and lymphatic vessel endothelial hyaluronan receptor-1, and western blot analysis for vascular endothelial growth factor receptor-3 (VEGFR3) and VEGF-C were performed. Results The circumferences of the limbs showed significant effects of group and time following surgery. The circumferences at the carpal joint and 2.5 cm above were smallest in the naïve limbs, larger in the Axilla+Forelimb/ESWT group, and the largest in the control group. VEGFR3 tended to be expressed at a higher level in the Axilla+Forelimb/ESWT group (1.96-fold) than in the Forelimb/ESWT group (1.20-fold) versus the opposite non-edematous forelimbs, although this difference was not statistically significant. Conclusions These data suggest that ESWT protocols have differential effects on angiogenesis and lymphangiogenesis in lymphedematous limbs.

[1]  S. Ohtori,et al.  Influence of different energy patterns on efficacy of radial shock wave therapy. , 2020, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[2]  Monya Baker,et al.  Reporting animal research: Explanation and Elaboration for the ARRIVE guidelines 2019 , 2019, bioRxiv.

[3]  A. Oğuz,et al.  Extracorporeal Shock Wave Therapy for Breast Cancer-Related Lymphedema: A Pilot Study. , 2016, Archives of physical medicine and rehabilitation.

[4]  J. Goldman,et al.  Fibrosis worsens chronic lymphedema in rodent tissues. , 2015, American journal of physiology. Heart and circulatory physiology.

[5]  H. Bae,et al.  Clinical Outcomes of Extracorporeal Shock Wave Therapy in Patients With Secondary Lymphedema: A Pilot Study , 2013, Annals of rehabilitation medicine.

[6]  J. Lee,et al.  Extracorporeal Shock Wave Therapy Combined with Vascular Endothelial Growth Factor-C Hydrogel for Lymphangiogenesis , 2012, Journal of Vascular Research.

[7]  H Shimokawa,et al.  Extracorporeal shock wave therapy induces therapeutic lymphangiogenesis in a rat model of secondary lymphoedema. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[8]  S. Wagner Lymphedema and lipedema - an overview of conservative treatment. , 2011, VASA. Zeitschrift fur Gefasskrankheiten.

[9]  Tao-Sheng Li,et al.  Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis. , 2010, Journal of vascular surgery.

[10]  I. Chekman,et al.  [Lymphedema: clinic-therapeutic aspect]. , 2010, Likars'ka sprava.

[11]  N. Harvey The Link between Lymphatic Function and Adipose Biology , 2008, Annals of the New York Academy of Sciences.

[12]  Yanli Liu,et al.  Effect of vascular endothelial growth factor C (VEGF-C) gene transfer in rat model of secondary lymphedema. , 2008, Vascular pharmacology.

[13]  A. G. Warren,et al.  Lymphedema: A Comprehensive Review , 2007, Annals of plastic surgery.

[14]  M. Swartz,et al.  Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. , 2006, Microvascular research.

[15]  Y. Kaneda,et al.  Transfection of Human Hepatocyte Growth Factor Gene Ameliorates Secondary Lymphedema via Promotion of Lymphangiogenesis , 2006, Circulation.

[16]  A. Saw Extracorporeal shock wave therapy for musculoskeletal pathology--a literature review. , 2005, The Medical journal of Malaysia.

[17]  C. Laronga,et al.  Lymphedema of the Arm and Breast in Irradiated Breast Cancer Patients: Risks in an Era of Dramatically Changing Axillary Surgery , 2003, The breast journal.

[18]  Kuender D Yang,et al.  Shock wave therapy induces neovascularization at the tendon–bone junction. A study in rabbits , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[19]  Y. Yoon,et al.  VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. , 2003, The Journal of clinical investigation.

[20]  M. Skobe,et al.  Therapeutic lymphangiogenesis with human recombinant VEGF‐C , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  Anne F. Williams,et al.  A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-related lymphoedema. , 2002, European journal of cancer care.

[22]  P. C. White,et al.  Surface acoustic cavitation understood via nanosecond electrochemistry. Part III: Shear stress in ultrasonic cleaning. , 2002, Ultrasonics sonochemistry.

[23]  D. Payne,et al.  Lymphedema , 2001, Cancer.

[24]  J. Ogden,et al.  Principles of shock wave therapy. , 2001, Clinical orthopaedics and related research.

[25]  K. Alitalo,et al.  Adenoviral Expression of Vascular Endothelial Growth Factor-C Induces Lymphangiogenesis in the Skin , 2001, Circulation research.

[26]  T. Veikkola,et al.  Signalling via vascular endothelial growth factor receptor‐3 is sufficient for lymphangiogenesis in transgenic mice , 2001, The EMBO journal.

[27]  J. Fareed,et al.  Transplantation of Lymph Node Fragments in a Rabbit Ear Lymphedema Model: A New Method for Restoring the Lymphatic Pathway , 1998, Plastic and reconstructive surgery.

[28]  J. Casley‐Smith Treatment of lymphedema by complex physical therapy, with and without oral and topical benzopyrones: what should therapists and patients expect. , 1996, Lymphology.

[29]  J. Daróczy Pathology of lymphedema. , 1995, Clinics in dermatology.